יישום של צג ה-EEG משולבת משרעת (תפקוד מוחי צג) על Neonates

Executive Industry Relevance

Amplitude-integrated EEG (aEEG) provides a non-invasive, bedside method for monitoring cerebral function in neonates, supporting early assessment of brain maturation and neurological risk. This technique enables real-time evaluation of physiological and pathological brain activity patterns, aiding in clinical decision-making for therapeutic interventions such as hypothermia cooling. Its accessibility in neonatal intensive care units facilitates continuous monitoring, contributing to predictive confidence in neurodevelopmental outcome stratification.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of cerebral function status to support therapeutic hypothesis testing in neonatal neuroprotection.
• Operational Value: Provides quantitative, real-time electrocortical readouts for pathway clarification and target engagement assessment.
• Predictive Value: Supports mechanistic de-risking by correlating early aEEG tracings with long-term neurodevelopmental outcomes.

Screening & Assay Development

• Scientific Value: Delivers standardized, reproducible background pattern classifications (continuous, discontinuous, burst suppression, flat trace) for assay readiness.
• Operational Value: Ensures signal quality through regular impedance and electrode dislocation checks, enabling reliable longitudinal monitoring.
• Translational Value: Facilitates preparation of validated neonatal models for downstream screening of neuroprotective compounds.

Translational & Preclinical Research

• Scientific Value: Offers disease-relevant system insights by linking aEEG patterns to pathophysiological conditions such as asphyxia and preterm brain injury.
• Operational Value: Enables raw EEG review to detect seizures or technical artefacts, enhancing data integrity in preclinical validation.
• Predictive Value: Supports risk-adjusted advancement decisions by identifying infants who may benefit from cooling therapy based on aEEG criteria.

Pipeline & Workflow Integration

aEEG monitoring fits within the early discovery continuum, supporting hypothesis testing in neonatal neurology and enabling quantitative assessment of cerebral function prior to lead identification in neuroprotective screening campaigns.

• Discovery Biology: Supports cerebral function status evaluation and brain maturation tracking in term and preterm infants.
• Screening: Delivers reproducible, quantitative voltage pattern outputs essential for compound effect comparison.
• Analytics: Provides measurable electrocortical readouts (e.g., upper/lower border shifts, seizure morphology) for condition comparison and artefact identification.
• Translational Research: Connects early aEEG patterns to long-term neurodevelopmental outcomes, supporting biomarker alignment.
• Enterprise Reuse: Represents a scalable, bedside-capable monitoring platform applicable across neonatal cohorts and study designs.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in neurodevelopmental risk, reduction of mechanistic ambiguity in neonatal brain injury models.
• Operational Value: Standardization, reproducibility, and scalability of cerebral function monitoring at the bedside.
• Strategic Value: Improved go/no-go decisions in neuroprotective programs, reduced late-stage biological risk through early outcome prediction.
• Portfolio Impact: Enables risk-adjusted prioritization of neonates for intervention based on aEEG-derived prognostic indicators.

Implementation Considerations

• Requires expertise in neonatal skin preparation, electrode placement, and impedance monitoring.
• Dependent on appropriate instrumentation (aEEG device, electrodes, gels, tapes) and infrastructure for signal acquisition.
• Necessitates cross-team standardization of electrode application and artefact marking protocols.
• Involves adaptation considerations for varying gestational ages and clinical conditions (e.g., preterm vs. term, asphyxia).
• Limited by the need for accurate fixation and localization of electrodes to avoid signal distortion or misinterpretation.

Biopharma FAQs